Daniel Bensen - 21 Mar 2023 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Operating Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
21 Mar 2023
Net transactions value
-$349,769
Form type
4
Filing time
23 Mar 2023, 19:47:49 UTC
Previous filing
08 Sep 2022
Next filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Options Exercise $8,601 +14,100 +2.7% $0.6100* 542,081 21 Mar 2023 Direct
transaction TYRA Common Stock Sale $225,600 -14,100 -2.6% $16.00 527,981 21 Mar 2023 Direct F1
transaction TYRA Common Stock Options Exercise $2,318 +3,800 +0.72% $0.6100* 531,781 22 Mar 2023 Direct
transaction TYRA Common Stock Sale $60,800 -3,800 -0.71% $16.00 527,981 22 Mar 2023 Direct F1
transaction TYRA Common Stock Options Exercise $2,944 +4,827 +0.91% $0.6100* 532,808 23 Mar 2023 Direct
transaction TYRA Common Stock Sale $77,232 -4,827 -0.91% $16.00 527,981 23 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -14,100 -5.2% $0.000000 256,029 21 Mar 2023 Common Stock 14,100 $0.6100 Direct F2
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -3,800 -1.5% $0.000000 252,229 22 Mar 2023 Common Stock 3,800 $0.6100 Direct F2
transaction TYRA Stock Option (Right to Buy) Options Exercise $0 -4,827 -1.9% $0.000000 247,402 23 Mar 2023 Common Stock 4,827 $0.6100 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in March 2022.
F2 25% of the shares subject to the option vested on January 27, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.